BI to pay $13.5 million for misleading marketing; ICER: CAR-T therapies more cost-effective than chemotherapy; FDA approves Roche’s breast cancer combo therapy
Five things for pharma marketers to know: Tuesday, December 12, 2017
FDA issues prescription drug promotion guidance; FDA approves first follow-on biologic of Lilly’s Humalog; drugmakers allegedly hired nurses to promote drugs
Five things for pharma marketers to know: Wednesday, July 26, 2017
CDC report finds prescription painkiller abuse contributed to an increase in heroin use; Novartis heart-failure drug gets FDA approval; Isis Pharmaceuticals obtains orphan-drug designation for volanesorsen
The year’s most popular stories
December 31, 2013
4:13 pm
Our year-end list captures the 10 that sparked heaviest interest.